Prostate Health Sensor

Prostate cancer is widespread in men

Prostate cancer is one of the most common malignant tumors diagnosed in men and ranks third in terms of death rates.

The risk increases significantly with age, which is why regular prostate examinations are urgently recommended from the age of 45 at the latest. After all, in many cases, it is possible to successfully treat prostate cancer with an early diagnosis.

Individual risk factors for prostate cancer

Age is considered the most significant risk factor for prostate cancer. However, genetic predisposition also plays a considerable role in determining whether a patient develops prostate cancer and how it ultimately progresses.

For this reason, a genetic test often makes sense. An analysis of the genes that are relevant for prostate cancer makes it possible to reliably assess the individual risk so that suitable measures can be taken if necessary.

This is how the Prostate Health Sensor works

For the Prostate Health Sensor, our laboratory comprehensively examines the sample sent in. Ten genetic variants associated with the development of prostate cancer are reviewed.

Also, we analyze the genetic profile of the patient concerning possible limitations in the efficacy and tolerability of 43 different drugs.

After successful completion of the analysis, we prepare a precise written evaluation with our results as well as concrete action measures, which can be recommended based on the test results

In this way, our Prostate Health Sensor helps to identify possible risks for prostate cancer early on and, if necessary, to counteract them in good time.

The Prostate Health Sensor at a glance:

• Analysis of 10 genetic variations relevant to prostate cancer
• Individual assessment of the risk of developing prostate cancer
• Investigation of the effects of the genetic profile on 43 drugs
• Reliable execution of the test in our laboratory
• A clear summary of the test results
• Concrete recommendations for action based on the results